According to the report of WHO, the incidence rate of liver cancer in China is 25.7/100,000, which is the highest in the world, and the new incidence and death of patients each year account for about half of the global total. Hepatitis B/Hepatitis C – Cirrhosis – Liver Cancer, this trilogy is experienced by most liver cancer patients. Clinical studies have found that 85% to 90% of liver cancers are related to hepatitis B. However, the length of time for the development of this trilogy is not definite and cannot be generalized, depending on factors such as patients’ individual differences, living habits and whether they are actively treated. Moreover, it doesn’t mean that having hepatitis B will definitely develop into liver cancer. As long as hepatitis B or hepatitis C patients are well controlled, a considerable percentage of them will not develop cirrhosis or liver cancer. Liver cancer is not a hereditary disease in the common sense. However, if there is a patient with liver cancer in the close relatives, do not take it lightly when the symptoms of liver cancer are suspected. However, if the patient has viral hepatitis, such as hepatitis B or C, and is in the active stage of viral hepatitis, the hepatitis virus may be transmitted through mother-to-child, blood and sexual contact.